Stefan Schulz - Publications

Affiliations: 
2006-2007 Pharmacology University of Jena, Jena, Thüringen, Germany 

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Miess E, Gondin AB, Yousuf A, Steinborn R, Mösslein N, Yang Y, Göldner M, Ruland JG, Bünemann M, Krasel C, Christie MJ, Halls ML, Schulz S, Canals M. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization. Science Signaling. 11. PMID 30018083 DOI: 10.1126/scisignal.aas9609  0.44
2016 Günther T, Culler M, Schulz S. Research Resource: Real-time analysis of somatostatin and dopamine receptor signaling in pituitary cells using a fluorescence-based membrane potential assay. Molecular Endocrinology (Baltimore, Md.). me20151241. PMID 26967369 DOI: 10.1210/me.2015-1241  0.6
2015 Moulédous L, Froment C, Burlet-Schiltz O, Schulz S, Mollereau C. Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor. Febs Letters. 589: 2401-8. PMID 26226422 DOI: 10.1016/j.febslet.2015.07.025  0.6
2015 Yousuf A, Miess E, Sianati S, Du YP, Schulz S, Christie M. The Role of Phosphorylation Sites in Desensitization of μ-Opioid Receptor. Molecular Pharmacology. PMID 25969388 DOI: 10.1124/mol.115.098244  0.6
2015 Kaemmerer D, Wirtz RM, Fischer EK, Hommann M, Sänger J, Prasad V, Specht E, Baum RP, Schulz S, Lupp A. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm. Pancreas. 44: 648-54. PMID 25872131 DOI: 10.1097/MPA.0000000000000316  0.6
2015 Bowman SL, Soohoo AL, Shiwarski DJ, Schulz S, Pradhan AA, Puthenveedu MA. Cell-autonomous regulation of Mu-opioid receptor recycling by substance P. Cell Reports. 10: 1925-36. PMID 25801029 DOI: 10.1016/j.celrep.2015.02.045  0.6
2015 Lupp A, Mann A, Heeb A, Kaemmerer D, Sänger J, Evert M, Evert K, Mawrin C, Schulz S. Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8. Peptides. 66: 19-25. PMID 25708416 DOI: 10.1016/j.peptides.2015.02.005  0.6
2015 Ádori C, Glück L, Barde S, Yoshitake T, Kovacs GG, Mulder J, Maglóczky Z, Havas L, Bölcskei K, Mitsios N, Uhlén M, Szolcsányi J, Kehr J, Rönnbäck A, Schwartz T, ... ... Schulz S, et al. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease. Acta Neuropathologica. 129: 541-63. PMID 25676386 DOI: 10.1007/s00401-015-1394-3  0.6
2015 Specht E, Kaemmerer D, Sänger J, Wirtz RM, Schulz S, Lupp A. Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms. Histopathology. PMID 25641082 DOI: 10.1111/his.12662  0.6
2015 Lee M, Lupp A, Mendoza N, Martin N, Beschorner R, Honegger J, Schlegel J, Shively T, Pulz E, Schulz S, Roncaroli F, Pellegata NS. SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary. Endocrine-Related Cancer. 22: 111-9. PMID 25515731 DOI: 10.1530/ERC-14-0472  0.6
2015 Kaemmerer D, Specht E, Sänger J, Wirtz RM, Sayeg M, Schulz S, Lupp A. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers. The Journal of Clinical Endocrinology and Metabolism. 100: 831-40. PMID 25494861 DOI: 10.1210/jc.2014-2699  0.6
2014 Ebbinghaus M, Gajda M, Holtzman MJ, Schulz S, Schaible HG. Does chloride channel accessory 3 have a role in arthritis pain? A study on murine antigen-induced arthritis. Neuroscience Letters. 576: 40-4. PMID 24905173 DOI: 10.1016/j.neulet.2014.05.051  0.6
2014 Madishetti S, Schneble N, König C, Hirsch E, Schulz S, Müller JP, Wetzker R. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. British Journal of Pharmacology. 171: 3328-37. PMID 24654606 DOI: 10.1111/bph.12698  0.6
2014 Lehmann A, Kliewer A, Märtens JC, Nagel F, Schulz S. Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms. Plos One. 9: e91526. PMID 24637622 DOI: 10.1371/journal.pone.0091526  0.6
2014 Glück L, Loktev A, Moulédous L, Mollereau C, Law PY, Schulz S. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5. Biological Psychiatry. 76: 767-74. PMID 24629717 DOI: 10.1016/j.biopsych.2014.01.021  0.6
2014 Lehmann A, Kliewer A, Schütz D, Nagel F, Stumm R, Schulz S. Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor. Molecular and Cellular Endocrinology. 387: 44-51. PMID 24565897 DOI: 10.1016/j.mce.2014.02.009  0.6
2014 Schulz S, Lehmann A, Kliewer A, Nagel F. Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5. British Journal of Pharmacology. 171: 1591-9. PMID 24328848 DOI: 10.1111/bph.12551  0.6
2013 Lambertini C, Barzaghi-Rinaudo P, D'Amato L, Schulz S, Nuciforo P, Schmid HA. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies. Regulatory Peptides. 187: 35-41. PMID 24188818 DOI: 10.1016/j.regpep.2013.10.007  0.6
2013 Mueller W, Schütz D, Nagel F, Schulz S, Stumm R. Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus. Plos One. 8: e64975. PMID 23734232 DOI: 10.1371/journal.pone.0064975  0.6
2013 Remke M, Hering E, Gerber NU, Kool M, Sturm D, Rickert CH, Gerß J, Schulz S, Hielscher T, Hasselblatt M, Jeibmann A, Hans V, Ramaswamy V, Taylor MD, Pietsch T, et al. Somatostatin receptor subtype 2 (sstâ‚‚) is a potential prognostic marker and a therapeutic target in medulloblastoma. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 29: 1253-62. PMID 23677175 DOI: 10.1007/s00381-013-2142-4  0.6
2013 Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ. Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacological Reviews. 65: 223-54. PMID 23321159 DOI: 10.1124/pr.112.005942  0.6
2010 Jacobs S, Calebiro D, Nikolaev VO, Lohse MJ, Schulz S. Real-time monitoring of somatostatin receptor-cAMP signaling in live pituitary. Endocrinology. 151: 4560-5. PMID 20610560 DOI: 10.1210/en.2010-0341  0.6
2010 Klenk C, Schulz S, Calebiro D, Lohse MJ. Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1. The Journal of Biological Chemistry. 285: 8665-74. PMID 20080964 DOI: 10.1074/jbc.M109.058685  0.6
2009 Schmitt JP, Ahmad F, Lorenz K, Hein L, Schulz S, Asahi M, Maclennan DH, Seidman CE, Seidman JG, Lohse MJ. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition. Circulation. 119: 436-44. PMID 19139388 DOI: 10.1161/CIRCULATIONAHA.108.783506  0.6
Show low-probability matches.